Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.
2.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
3.

Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.

Lako IM, van den Heuvel ER, Knegtering H, Bruggeman R, Taxis K.

J Clin Psychopharmacol. 2013 Oct;33(5):675-81. doi: 10.1097/JCP.0b013e3182983ffa. Review.

PMID:
23948784
4.
5.

Implications of brain imaging for the management of schizophrenia.

Nyberg S, Nilsson U, Okubo Y, Halldin C, Farde L.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S15-20. Review.

PMID:
9690965
6.
7.

Mechanism of new antipsychotic medications: occupancy is not just antagonism.

Grunder G, Carlsson A, Wong DF.

Arch Gen Psychiatry. 2003 Oct;60(10):974-7. Review.

PMID:
14557141
8.

Relationship between daily dose, plasma concentrations, dopamine receptor occupancy, and clinical response to quetiapine: a review.

Sparshatt A, Taylor D, Patel MX, Kapur S.

J Clin Psychiatry. 2011 Aug;72(8):1108-23. doi: 10.4088/JCP.09r05739yel. Epub 2011 Jan 25. Review.

PMID:
21294996
10.
11.

Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.

Nemeroff CB, Kinkead B, Goldstein J.

J Clin Psychiatry. 2002;63 Suppl 13:5-11. Review.

12.

The current status of PET scanning with respect to schizophrenia.

Sedvall G.

Neuropsychopharmacology. 1992 Aug;7(1):41-54. Review.

PMID:
1388021
13.

Quetiapine: a review of its use in the management of bipolar depression.

Sanford M, Keating GM.

CNS Drugs. 2012 May 1;26(5):435-60. doi: 10.2165/11203840-000000000-00000. Review.

PMID:
22519923
14.

Antipsychotic efficacy: relationship to optimal D2-receptor occupancy.

Pani L, Pira L, Marchese G.

Eur Psychiatry. 2007 Jul;22(5):267-75. Epub 2007 Apr 6. Review.

PMID:
17419008
15.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
16.

Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia.

Kasper S, Tauscher J, Küfferle B, Barnas C, Pezawas L, Quiner S.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 4:83-9. Review.

PMID:
10654113
17.

[Receptor occupancy and antipsychotic drug action measured by PET and SPECT].

Okubo Y, Suhara T.

Seishin Shinkeigaku Zasshi. 2001;103(4):329-40. Review. Japanese.

PMID:
11392846
18.

[Quetiapine].

Kusumi I.

Nihon Rinsho. 2013 Apr;71(4):673-7. Review. Japanese.

PMID:
23678598
19.

Antipsychotic occupancy of dopamine receptors in schizophrenia.

Nord M, Farde L.

CNS Neurosci Ther. 2011 Apr;17(2):97-103. doi: 10.1111/j.1755-5949.2010.00222.x. Epub 2010 Dec 8. Review.

PMID:
21143431
20.

Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench.

Kapur S, Wadenberg ML, Remington G.

Can J Psychiatry. 2000 Apr;45(3):241-6. Review.

PMID:
10779880

Supplemental Content

Support Center